These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 30103646)

  • 1. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
    Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
    Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort.
    Chen HH; Chen YM; Chen TJ; Lan JL; Lin CH; Chen DY
    Clinics (Sao Paulo); 2011; 66(7):1177-82. PubMed ID: 21876970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of infective endocarditis in patients with systemic lupus erythematosus in Taiwan: a nationwide population-based study.
    Chang YS; Chang CC; Chen YH; Chen WS; Chen JH
    Lupus; 2017 Oct; 26(11):1149-1156. PubMed ID: 28420053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
    González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
    Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
    Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
    J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus.
    Kabadi S; Yeaw J; Bacani AK; Tafesse E; Bos K; Karkare S; DeKoven M; Vina ER
    Lupus; 2018 Oct; 27(11):1799-1809. PubMed ID: 30068254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.
    Pryor BD; Bologna SG; Kahl LE
    Arthritis Rheum; 1996 Sep; 39(9):1475-82. PubMed ID: 8814058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
    Ferreira JC; Marques HH; Ferriani MP; Gormezano NW; Terreri MT; Pereira RM; Magalhães CS; Campos LM; Bugni V; Okuda EM; Marini R; Pileggi GS; Barbosa CM; Bonfá E; Silva CA
    Lupus; 2016 Jun; 25(7):754-9. PubMed ID: 26821966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection in systemic lupus erythematosus.
    Janwityanuchit S; Totemchokchyakarn K; Krachangwongchai K; Vatanasuk M
    J Med Assoc Thai; 1993 Oct; 76(10):542-8. PubMed ID: 7964223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage in systemic lupus erythematosus and its association with corticosteroids.
    Zonana-Nacach A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
    Zamora LD; Collante MTM; Navarra SV
    Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of herpes zoster infection with clinical characteristics and MBL2 gene polymorphisms in Chinese children with systemic lupus erythematosus.
    Wu SA; Yeh KW; Yao TC; Huang JL
    Pediatr Infect Dis J; 2011 Aug; 30(8):656-60. PubMed ID: 21343839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
    Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
    Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
    J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of interstitial cystitis among patients with systemic lupus erythematosus: A population-based cohort study.
    Wen JY; Lo TS; Chuang YC; Ho CH; Long CY; Law KS; Tong YC; Wu MP
    Int J Urol; 2019 Sep; 26(9):897-902. PubMed ID: 31311067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.
    Desai RJ; Bateman BT; Huybrechts KF; Patorno E; Hernandez-Diaz S; Park Y; Dejene SZ; Cohen J; Mogun H; Kim SC
    BMJ; 2017 Mar; 356():j895. PubMed ID: 28264814
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of systemic lupus erythematosus in patients with human papillomavirus infection: a population-based retrospective cohort study.
    Shi LH; Huang JY; Liu YZ; Chiou JY; Wu R; Wei JC
    Lupus; 2018 Dec; 27(14):2279-2283. PubMed ID: 30451639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
    Rascu A; Manger K; Kraetsch HG; Kalden JR; Manger B
    Lupus; 1996 Aug; 5(4):323-7. PubMed ID: 8869906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.